An Italian-based pharmaceutical company with subsidiaries in New York has been granted orphan drug status for a new drug to treat neurotrophic keratitis, a rare degenerative corneal disease that impacts less than 1 in 5,000 people worldwide.
Diabetic autonomic neuropathy, a common side effect of diabetes that is linked to a wide range of complications including digestive issues, erectile dysfunction, paralysis of the bladder and intestinal damage, is not only difficult to treat, it’s also difficult to diagnose.
Having diabetes increases the risk of complications or death in cases where patients have suffered polytrauma compared with patients who don't have any history of medical comorbidities. (Comorbidities are defined as the simultaneous presence of two chronic diseases in a patient.)
Polytrauma is defined as multiple injuries to the body or organs where at least one is life-threatening and exacerbated by the trauma of the other injuries. Such injuries usually occur in situations where the likelihood of substantial injury is high---falls, auto accidents, violent crimes, industrial accidents.
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.